甲状腺激素检测对老年慢性心力衰竭患者病情评估的临床意义研究被引量：1

Clinical Significance of Thyroid Hormone Testing for Condition Assessment of Elderly Patients with Chronic Heart Failure

下载PDF

导出

摘要目的探究甲状腺激素检测对老年慢性心力衰竭患者病情评估的价值。方法回顾性分析2011年6月至2014年5月我院治疗的120例患者的临床记录资料,其中的80例为老年慢性心力衰竭患者,其余40例为其他病因住院治疗的患者。结果老年慢性心力衰竭组患者的FT3、TT3明显低于对照组,差异显著(P<0.05),且患者心力衰竭越重,差异越大;但老年慢性心力衰竭组的FT4、TT4与对照组无显著差异(P>0.05),不具有统计学意义。结论甲状腺激素检测对老年慢性心力衰竭患者病情评估具有重要的指导意义,可根据患者的FT3、TT3水平评估其病情。 Objective To investigate clinical significance of thyroid hormone testing for condition assessment of elderly patients with chronic heart failure. Methods The clinical records of 120 patients in our hospital from June 2011 to May 2014 were analyzed, 80 cases of elderly patients with chronic heart failure, and the remaining 40 cases of patients for other causes. Results FT3 and TT3 of elderly patients with chronic heart failure were significantly lower than the control group（P 0.05）, and the higher the level, the greater the difference; FT4 and TT4 of elderly patients with chronic heart failure were not significant difference the control group（P〈0.05）. Conclusion Thyroid hormone testing for condition assessment of elderly patients with chronic heart failure has important guiding significance,it can be assessed based on the patient of FT3, TT3 level.

作者卞野赵春生

机构地区吉林省四平市中心医院吉林省四平市妇婴医院

出处《中国医药指南》 2016年第17期26-27,共2页 Guide of China Medicine

关键词甲状腺激素检测老年慢性心力衰竭病情评估 Thyroid hormone testing Chronic heart failure Condition assessment

分类号 R541.61 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献7

1汪红平,任颖,魏盟,邵琦,高婧.慢性心力衰竭伴非甲状腺性病态综合征的研究[J].中华临床医师杂志（电子版）,2012,6(8):80-84. 被引量：4
2刘德志,温强.老年慢性心力衰竭患者甲状腺激素测定的临床价值[J].中国现代药物应用,2012,6(1):34-35. 被引量：3
3Lymvaios I.Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction:a strong association[J].Eur J Endocrinol,2011,165(4):107-114.
4Martocchia A,Cola S,Frugoni P,et al.The burden of comorbidity and the C-reactive protein levels in nonthyroidal illness syndrome with metabolic syndrome and atherosclerosis-related cardiovascular complications[J].Ann N Y Acad Sci,2010,1193(1):164-166.
5Silva-Tinoco R.Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure[J].Int J Cardiol,2011,147(1):24-25.
6Iglesias P,Diez JJ.Thyroid dysfunction and kidney disease[J].Eur J Endocrinol,2009,160(6):503-515.
7Novack V,Pencina M,Zahger D,et al.Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure[J].PLo S One,2010,7(5):12184.

二级参考文献19

1梁飞宇,屈晓冰.心力衰竭与正常甲状腺病态综合征[J].国外医学（心血管疾病分册）,2005,32(1):15-17. 被引量：11
2Martocchia A,Cola S,Frugoni P. The burden of comorbidity and the C-reactive protein levels in nonthyroidal illness syndrome with metabolic syndrome and atherosclerosis-related cardiovascular complications[J].Annals of the New York Academy of Sciences,2010.164-166.
3Lymvaios I,Mourouzis I,Cokkinos DV. Thyroid hormone and recovery of cardiac function in patients with acute myocardial infarction:a strong association[J].European Journal of Endocrinology,2011.107-114.
4Passino C,Pingitore A,Landi P. Prognostic value of combined measurement of brain natriuretic peptide and triiodothyronine in heart failure[J].Journal of Cardiac Failure,2009.35-40.
5Dickstein K,Cohen-Solal A,Filippatos G. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008:the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC(HFA)and endorsed by the European Society of Intensive Care Medicine(ESICM)[J].European Journal of Heart Failure,2008,(10):933-989.doi:10.1016/j.ejheart.2008.08.005.
6Klein I,Danzi S. Thyroid disease and the heart[J].Circulation,2007.1725-1735.
7Silva-Tinoco R,Castillo-Martinez L,Orea-Tejeda A. Developing thyroid disorders is associated with poor prognosis factors in patient with stable chronic heart failure[J].International Journal of Cardiology,2011.24-25.
8Heuer H,Visser TJ. Minireview:Pathophysiological importance of thyroid hormone transporters[J].Endocrinology,2009.1078-1083.
9Mohammed AA,Van Kimmenade RR,Richards M. Hyponatremia,natriuretic peptides,and outcomes in acutely decompensated heart failure:results from the International Collaborative of NT-proBNP Study[J].Circ Heart Fail,2010.354-361.
10Novack V,Pencina M,Zahger D. Routine laboratory results and thirty day and one-year mortality risk following hospitalization with acute decompensated heart failure[J].PLoS One,2010.12184.doi:10.1371/journal.pone.0012184.